Fuller & Thaler Asset Management
CORT icon

Fuller & Thaler Asset Management’s Corcept Therapeutics CORT Stock Holding History

Fuller & Thaler Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.7M Buy
+710,106
New +$42.9M 0.17% 198
2018
Q3 		– Sell
-438,342
Closed -$6.89M – 515
2018
Q2 		$6.89M Buy
+438,342
New +$7.63M 0.07% 180
2018
Q1 		– Sell
-440,300
Closed -$7.95M – 774
2017
Q4 		$7.95M Buy
440,300
+295,200
+203% +$5.35M 0.1% 147
2017
Q3 		$2.8M Buy
145,100
+89,700
+162% +$1.34M 0.03% 215
2017
Q2 		$654K Hold
55,400
– – 0.01% 304
2017
Q1 		$607K Buy
55,400
+10,800
+24% +$94.9K 0.01% 298
2016
Q4 		$324K Buy
44,600
+36,100
+425% +$283K ﹤0.01% 326
2016
Q3 		$55K Buy
+8,500
New +$49.4K ﹤0.01% 569

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fuller & Thaler Asset Management's CORT Position: Q2 2026 in Review

Fuller & Thaler Asset Management opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 710,106 shares worth $61.7M. The stake represents 0.17% of the portfolio and ranks #198 among its holdings. This is a return to the name: Fuller & Thaler Asset Management previously reported a position in CORT as recently as Q2 2018.

Fuller & Thaler Asset Management first reported a position in CORT in Q3 2016 and has held it in 8 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Fuller & Thaler Asset Management held 710,106 shares of Corcept Therapeutics worth $61.7M as of Q2 2026.
  • Corcept Therapeutics was a new Fuller & Thaler Asset Management position in Q2 2026.
  • Corcept Therapeutics made up 0.17% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #198 holding.
  • Fuller & Thaler Asset Management first reported a position in Corcept Therapeutics in Q3 2016 and has held it in 8 quarters since.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.